Managed care
Southern California Permanente Medical Group
Southern California Permanente Medical Group was paid $17.76M by Medicaid between Jan 2018 and Dec 2024, across 490 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 19% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
ANAHEIM, CA 92807
ANAHEIM, CA 92807
33aNPI1952333460assigned 07/07/2006
33bProvider typeHealth Maintenance Organization
28Total paid$17.76M
24GClaims2,739,737
24DCodes billed490
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#12 of 151
Median peer was paid$59K
This provider vs. median301×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,977 | $62K | |
| 2019 | 421,700 | $95K | |
| 2020 | 372,765 | $63K | |
| 2021 | 481,919 | $1.14M | |
| 2022 | 539,881 | $511K | |
| 2023 | 481,271 | $420K | |
| 2024incomplete | 401,224 | $15.47M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 213,285 | 196,935 | $3.34M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.7% | 45,739 | 43,732 | $1.72M |
| 91320 | 8.0% | 11,951 | 11,948 | $1.42M | |
| 90480 | 3.4% | 16,472 | 16,453 | $612K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.4% | 28,806 | 21,357 | $605K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.3% | 9,028 | 6,654 | $589K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.2% | 205,005 | 186,000 | $562K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.4% | 9,982 | 9,051 | $433K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.3% | 10,507 | 10,088 | $408K |
| 90662 | 1.9% | 3,047 | 3,044 | $336K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.6% | 172,348 | 170,001 | $280K |
| 67028 | Intravitreal injection of a pharmacologic agent | 1.5% | 2,682 | 2,594 | $266K |
478 more codes
| 0001A | 1.4% | 6,841 | $246K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.4% | 21,651 | $242K |
| 0002A | 1.4% | 6,659 | $242K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 79,600 | $223K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.3% | 19,928 | $223K |
| 0012A | 1.1% | 5,210 | $189K | |
| 0011A | <1% | 5,128 | $173K | |
| 99283 | Emergency room visit (moderate) | <1% | 19,960 | $172K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 5,236 | $172K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 29,325 | $167K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 7,363 | $157K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 30,720 | $152K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 7,877 | $148K |
| 92015 | Determination of refractive state | <1% | 43,992 | $133K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 1,265 | $131K |
| 0064A | <1% | 3,628 | $130K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 10,007 | $124K |
| 77080 | <1% | 4,919 | $122K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,225 | $117K |
| 11721 | <1% | 1,988 | $102K | |
| 90837 | Psychotherapy session, about an hour | <1% | 14,767 | $101K |
| 76536 | <1% | 4,421 | $82K | |
| 0004A | <1% | 2,231 | $81K | |
| 95800 | <1% | 663 | $80K | |
| 76830 | Ultrasound, transvaginal | <1% | 12,216 | $76K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14,064 | $75K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 19,935 | $74K |
| 93970 | <1% | 1,092 | $71K | |
| 0071A | <1% | 1,844 | $70K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 5,755 | $70K |
| 93268 | <1% | 702 | $67K | |
| 73630 | <1% | 15,801 | $65K | |
| 73562 | <1% | 9,584 | $65K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 18,566 | $63K |
| 76770 | <1% | 4,320 | $63K | |
| 93880 | <1% | 150 | $62K | |
| 73030 | <1% | 9,723 | $59K | |
| 73564 | <1% | 7,008 | $59K | |
| 71045 | Radiologic examination, chest; single view | <1% | 26,059 | $56K |
| 92002 | <1% | 12,483 | $53K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 3,446 | $53K |
| 0124A | <1% | 1,831 | $52K | |
| 72100 | <1% | 6,683 | $48K | |
| 92557 | <1% | 2,483 | $48K | |
| 77065 | Tomosynthesis, mammo | <1% | 1,491 | $47K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 8,020 | $47K |
| 0072A | <1% | 1,289 | $47K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 2,039 | $46K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,722 | $45K |
| 73502 | <1% | 3,804 | $44K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 4,911 | $42K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 20,132 | $41K |
| 0134A | <1% | 1,270 | $39K | |
| 92134 | <1% | 4,957 | $38K | |
| 90656 | <1% | 7,729 | $38K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 20,593 | $38K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 327 | $38K |
| 64615 | <1% | 826 | $37K | |
| 92551 | <1% | 51,932 | $36K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 21,939 | $36K |
| 76642 | <1% | 4,305 | $35K | |
| 0054A | <1% | 1,012 | $35K | |
| 93971 | <1% | 1,716 | $34K | |
| 99441 | <1% | 28,657 | $34K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 2,352 | $32K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 26,082 | $32K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 2,084 | $31K |
| 73130 | <1% | 7,456 | $31K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,470 | $29K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 1,151 | $29K |
| 73610 | <1% | 10,632 | $27K | |
| 0031A | <1% | 679 | $27K | |
| 80051 | <1% | 14,201 | $27K | |
| 73110 | <1% | 6,813 | $26K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 10,692 | $26K |
| 82565 | <1% | 16,863 | $26K | |
| 77066 | Tomosynthesis, mammo | <1% | 1,261 | $25K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 580 | $24K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,522 | $24K |
| 92567 | <1% | 3,548 | $23K | |
| 97161 | <1% | 8,211 | $22K | |
| 83880 | <1% | 966 | $22K | |
| 11055 | <1% | 728 | $22K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 24,137 | $21K |
| 20610 | <1% | 2,694 | $20K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 15,005 | $20K |
| 95806 | <1% | 230 | $20K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 25,443 | $20K |
| 74018 | <1% | 8,955 | $19K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 1,566 | $19K |
| 96116 | <1% | 5,642 | $19K | |
| 90686 | <1% | 69,431 | $19K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 18,269 | $17K |
| 73140 | <1% | 6,270 | $16K | |
| 71250 | <1% | 1,227 | $16K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 5,716 | $15K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 3,700 | $15K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 16,000 | $15K |
| 84460 | <1% | 10,568 | $14K | |
| 72040 | <1% | 2,563 | $14K | |
| 76706 | <1% | 69 | $14K | |
| 72050 | <1% | 1,966 | $14K | |
| 91319 | <1% | 809 | $14K | |
| 82247 | <1% | 10,869 | $14K | |
| 73523 | <1% | 332 | $13K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 1,740 | $13K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 41,490 | $12K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | <1% | 694 | $11K |
| 31231 | <1% | 726 | $11K | |
| 84520 | <1% | 11,357 | $11K | |
| 71101 | <1% | 1,595 | $11K | |
| 84075 | <1% | 8,342 | $10K | |
| 82947 | <1% | 12,261 | $10K | |
| 83921 | <1% | 494 | $10K | |
| 90674 | <1% | 20,275 | $10K | |
| 92523 | <1% | 1,830 | $10K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 2,012 | $9K |
| 76870 | <1% | 1,825 | $9K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,120 | $9K |
| 81206 | <1% | 128 | $9K | |
| 73080 | <1% | 3,434 | $9K | |
| 84484 | <1% | 2,519 | $9K | |
| 73522 | <1% | 412 | $9K | |
| 99173 | <1% | 36,873 | $8K | |
| 99443 | <1% | 2,941 | $8K | |
| 84450 | <1% | 4,536 | $8K | |
| 90677 | <1% | 2,937 | $8K | |
| 91318 | <1% | 680 | $7K | |
| 73660 | <1% | 2,231 | $7K | |
| 81329 | <1% | 703 | $7K | |
| 93923 | <1% | 25 | $7K | |
| 85610 | <1% | 4,452 | $6K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 770 | $6K |
| 83690 | <1% | 5,293 | $6K | |
| 76881 | <1% | 1,896 | $6K | |
| 0052A | <1% | 147 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,122 | $6K |
| 73590 | <1% | 2,504 | $5K | |
| 92550 | <1% | 661 | $5K | |
| 73560 | <1% | 1,196 | $5K | |
| 73552 | <1% | 299 | $5K | |
| 73100 | <1% | 1,917 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 19,765 | $5K |
| 0051A | <1% | 128 | $5K | |
| 74220 | <1% | 51 | $5K | |
| 0074A | <1% | 181 | $5K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 4,321 | $5K |
| 0013A | <1% | 124 | $5K | |
| 0154A | <1% | 148 | $5K | |
| 99223 | Prolong inpt eval add15 m | <1% | 1,571 | $5K |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 5,174 | $5K |
| 84702 | <1% | 4,297 | $5K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,438 | $5K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,554 | $5K |
| 73060 | <1% | 347 | $5K | |
| 93922 | <1% | 26 | $5K | |
| 72070 | <1% | 1,049 | $4K | |
| 86360 | <1% | 1,079 | $4K | |
| 74230 | <1% | 27 | $4K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 571 | $4K |
| 85060 | <1% | 668 | $4K | |
| 0003A | <1% | 115 | $4K | |
| 81003 | <1% | 10,482 | $4K | |
| 70486 | <1% | 1,164 | $4K | |
| 88342 | <1% | 1,644 | $4K | |
| 86359 | <1% | 1,079 | $4K | |
| 73090 | <1% | 2,382 | $4K | |
| 99205 | Prolong outpt/office vis | <1% | 1,529 | $3K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,416 | $3K |
| 85027 | <1% | 2,838 | $3K | |
| 88304 | <1% | 2,824 | $3K | |
| 76641 | <1% | 298 | $3K | |
| 72080 | <1% | 135 | $3K | |
| 76801 | <1% | 1,113 | $3K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,799 | $3K |
| 77073 | <1% | 59 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 6,213 | $3K |
| 99417 | Prolong home eval add 15m | <1% | 1,024 | $3K |
| 81207 | <1% | 28 | $3K | |
| 99152 | <1% | 51 | $2K | |
| 72141 | <1% | 1,060 | $2K | |
| 90651 | <1% | 12,606 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,296 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,961 | $2K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 108 | $2K |
| 90678 | <1% | 13 | $2K | |
| 11056 | <1% | 12 | $2K | |
| 82310 | <1% | 774 | $2K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 284 | $2K |
| 73000 | <1% | 482 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 60 | $2K |
| 82105 | <1% | 842 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 2,619 | $2K |
| 88189 | <1% | 16 | $2K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 637 | $2K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 78,897 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 67,254 | $2K |
| 59514 | <1% | 465 | $2K | |
| 90670 | <1% | 14,006 | $2K | |
| 0082A | <1% | 41 | $2K | |
| 99442 | <1% | 9,226 | $2K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 557 | $1K |
| 72220 | <1% | 111 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,560 | $1K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 165 | $1K |
| 99219 | <1% | 1,503 | $1K | |
| 90723 | <1% | 9,831 | $1K | |
| 90648 | <1% | 14,288 | $1K | |
| 81270 | <1% | 26 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 18,648 | $1K |
| 77072 | <1% | 601 | $1K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,861 | $1K |
| 72120 | <1% | 26 | $1K | |
| 0112A | <1% | 31 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,799 | $1K |
| 72081 | <1% | 1,715 | $1K | |
| 78451 | <1% | 12 | $1K | |
| 90734 | <1% | 9,716 | $1K | |
| 73070 | <1% | 812 | $1K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 1,851 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 804 | $1K |
| 12001 | <1% | 271 | $1K | |
| 94060 | <1% | 529 | $1K | |
| 73650 | <1% | 161 | $1K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 771 | $999.28 |
| 82248 | <1% | 1,127 | $997.43 | |
| 70360 | <1% | 323 | $992.18 | |
| 73221 | <1% | 407 | $969.04 | |
| 73120 | <1% | 539 | $921.42 | |
| 99221 | <1% | 2,425 | $856.98 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 197 | $841.00 |
| 90681 | <1% | 4,863 | $839.85 | |
| 92136 | <1% | 13 | $807.00 | |
| 76813 | <1% | 855 | $765.37 | |
| 92133 | <1% | 1,837 | $753.24 | |
| 92587 | <1% | 813 | $725.28 | |
| 0053A | <1% | 18 | $720.00 | |
| 88307 | <1% | 1,147 | $647.93 | |
| 90660 | <1% | 86 | $646.00 | |
| 91200 | <1% | 45 | $638.00 | |
| 57454 | <1% | 642 | $632.12 | |
| 84132 | <1% | 252 | $622.88 | |
| 43235 | <1% | 766 | $622.54 | |
| 00840 | <1% | 1,093 | $619.20 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,128 | $591.32 |
| 99225 | <1% | 963 | $591.14 | |
| 70491 | <1% | 336 | $580.85 | |
| 99234 | <1% | 197 | $528.14 | |
| 0081A | <1% | 13 | $523.78 | |
| 90750 | <1% | 5,579 | $513.99 | |
| 58300 | <1% | 1,471 | $504.66 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 185 | $504.51 |
| 0111A | <1% | 12 | $480.00 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 1,234 | $448.26 |
| 93016 | <1% | 132 | $448.05 | |
| 10060 | <1% | 309 | $441.09 | |
| 85379 | <1% | 591 | $434.05 | |
| 00790 | <1% | 286 | $432.53 | |
| 90655 | <1% | 154 | $420.00 | |
| 81002 | <1% | 14,966 | $396.57 | |
| 90715 | <1% | 15,974 | $391.98 | |
| 17110 | <1% | 3,335 | $390.10 | |
| 83605 | <1% | 395 | $390.00 | |
| 94726 | <1% | 238 | $381.15 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 24 | $378.00 |
| 95117 | <1% | 890 | $363.00 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 620 | $335.00 |
| 88341 | <1% | 1,004 | $319.88 | |
| 99217 | <1% | 1,062 | $317.71 | |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 683 | $305.63 |
| 93018 | <1% | 133 | $300.65 | |
| 99421 | <1% | 33 | $300.00 | |
| 11750 | <1% | 637 | $296.60 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,297 | $293.90 |
| 11102 | <1% | 1,126 | $280.62 | |
| 98968 | <1% | 2,002 | $280.00 | |
| 90633 | <1% | 9,569 | $270.52 | |
| 99460 | <1% | 2,316 | $252.16 | |
| 58100 | <1% | 1,428 | $238.03 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 12 | $236.00 |
| 59025 | Fetal non-stress test | <1% | 822 | $227.40 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,329 | $215.39 |
| 76882 | <1% | 15 | $200.00 | |
| 73620 | <1% | 14 | $184.82 | |
| 99188 | <1% | 2,703 | $178.00 | |
| 85730 | <1% | 366 | $175.63 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 213 | $170.77 |
| 69209 | <1% | 3,360 | $170.03 | |
| 84295 | <1% | 30 | $170.00 | |
| 69210 | <1% | 414 | $169.80 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 17 | $164.28 |
| 99201 | <1% | 5,397 | $164.23 | |
| 86800 | <1% | 13 | $158.95 | |
| 70496 | <1% | 43 | $148.98 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 220 | $148.94 |
| 70498 | <1% | 28 | $148.50 | |
| 31575 | <1% | 534 | $147.07 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 10,879 | $137.90 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 339 | $130.70 |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 26 | $120.76 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,861 | $109.34 |
| 97597 | <1% | 596 | $108.80 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 449 | $103.25 |
| 81025 | <1% | 11,103 | $103.18 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 9,605 | $98.47 |
| 92083 | <1% | 597 | $97.96 | |
| 90707 | <1% | 5,347 | $97.28 | |
| 93015 | <1% | 222 | $94.95 | |
| 12011 | <1% | 58 | $92.02 | |
| 20550 | <1% | 666 | $91.12 | |
| 99385 | <1% | 2,504 | $85.57 | |
| 52000 | <1% | 145 | $80.00 | |
| 90732 | <1% | 1,387 | $76.55 | |
| 92579 | <1% | 750 | $76.29 | |
| 97165 | <1% | 1,025 | $69.68 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 6,251 | $68.81 |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,018 | $63.03 |
| 11900 | <1% | 1,218 | $62.23 | |
| 96127 | <1% | 1,155 | $62.00 | |
| 72146 | <1% | 100 | $61.39 | |
| 90700 | <1% | 4,808 | $57.27 | |
| 99354 | <1% | 256 | $57.06 | |
| 20552 | <1% | 340 | $52.49 | |
| 74022 | <1% | 282 | $52.03 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $51.31 |
| 74178 | <1% | 73 | $50.00 | |
| 58301 | <1% | 976 | $48.64 | |
| 87338 | <1% | 298 | $46.52 | |
| 90672 | <1% | 871 | $44.00 | |
| 62323 | <1% | 129 | $43.68 | |
| 36620 | <1% | 14 | $42.07 | |
| L1810 | Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 396 | $41.40 |
| 11730 | <1% | 128 | $40.38 | |
| 99220 | <1% | 105 | $40.15 | |
| 85652 | <1% | 1,493 | $39.79 | |
| 51798 | <1% | 625 | $39.50 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,975 | $34.87 |
| 97162 | <1% | 258 | $34.84 | |
| 99307 | <1% | 30 | $33.96 | |
| 90716 | <1% | 5,114 | $33.75 | |
| 90744 | <1% | 333 | $33.22 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,174 | $32.94 |
| 17000 | <1% | 590 | $32.01 | |
| 94010 | <1% | 332 | $30.00 | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 405 | $28.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,045 | $25.23 |
| 99051 | <1% | 32,394 | $22.61 | |
| D1206 | Topical application of fluoride varnish | <1% | 686 | $18.00 |
| 81015 | <1% | 64 | $16.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,531 | $14.67 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,281 | $12.76 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,997 | $11.70 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 641 | $10.24 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 8,200 | $10.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,263 | $8.84 |
| 88720 | <1% | 344 | $8.13 | |
| 96415 | <1% | 586 | $8.08 | |
| 96146 | <1% | 203 | $7.68 | |
| 11200 | <1% | 131 | $5.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,533 | $3.45 |
| 86580 | <1% | 5,523 | $3.33 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,592 | $1.61 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 184 | $0.92 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,218 | $0.77 |
| G9920 | Screening performed and negative | <1% | 12,561 | $0.16 |
| 1036F | <1% | 57,288 | $0.01 | |
| 90696 | 0% | 5,115 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 320 | $0.00 |
| 90739 | 0% | 424 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 2,024 | $0.00 |
| 3044F | 0% | 383 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 853 | $0.00 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 0% | 300 | $0.00 |
| 3074F | 0% | 3,774 | $0.00 | |
| 82962 | 0% | 1,950 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 245 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 71 | $0.00 |
| 99024 | 0% | 6,609 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 12 | $0.00 |
| 3075F | 0% | 1,837 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 48 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 598 | $0.00 |
| 3079F | 0% | 1,770 | $0.00 | |
| 99462 | 0% | 139 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 187 | $0.00 |
| 97010 | 0% | 365 | $0.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 246 | $0.00 |
| 99412 | 0% | 12 | $0.00 | |
| 93241 | 0% | 75 | $0.00 | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 0% | 623 | $0.00 |
| 97166 | 0% | 26 | $0.00 | |
| 94761 | 0% | 283 | $0.00 | |
| 99386 | 0% | 934 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 361 | $0.00 |
| 87807 | 0% | 188 | $0.00 | |
| 82043 | 0% | 54 | $0.00 | |
| 99402 | 0% | 122 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 167 | $0.00 |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 0% | 39 | $0.00 |
| 92522 | 0% | 68 | $0.00 | |
| 98967 | 0% | 60 | $0.00 | |
| 29075 | 0% | 12 | $0.00 | |
| 99140 | 0% | 31 | $0.00 | |
| 74183 | 0% | 79 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 151 | $0.00 |
| 44970 | 0% | 25 | $0.00 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 0% | 16 | $0.00 |
| 92227 | 0% | 19 | $0.00 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 0% | 75 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 13 | $0.00 |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 0% | 12 | $0.00 |
| 95910 | 0% | 40 | $0.00 | |
| 90839 | 0% | 13 | $0.00 | |
| 90620 | 0% | 43 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 31 | $0.00 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 30 | $0.00 |
| 90632 | 0% | 32 | $0.00 | |
| 95819 | 0% | 14 | $0.00 | |
| 87088 | 0% | 70 | $0.00 | |
| 46600 | 0% | 16 | $0.00 | |
| 90381 | 0% | 17 | $0.00 | |
| 72170 | 0% | 22 | $0.00 | |
| 95012 | 0% | 27 | $0.00 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 0% | 873 | $0.00 |
| G0168 | Wound closure utilizing tissue adhesive(s) only | 0% | 25 | $0.00 |
| 96523 | 0% | 327 | $0.00 | |
| 99177 | 0% | 16,851 | $0.00 | |
| 90710 | 0% | 5,169 | $0.00 | |
| 90746 | 0% | 1,599 | $0.00 | |
| 90713 | 0% | 340 | $0.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 0% | 190 | $0.00 |
| 54150 | 0% | 334 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 142 | $0.00 |
| 4004F | 0% | 3,328 | $0.00 | |
| L3260 | Surgical boot/shoe, each | 0% | 282 | $0.00 |
| 76857 | 0% | 93 | $0.00 | |
| S9480 | Intensive outpatient psychiatric services, per diem | 0% | 1,694 | $0.00 |
| J1071 | Injection, testosterone cypionate, 1 mg | 0% | 2,376 | $0.00 |
| 88312 | 0% | 186 | $0.00 | |
| 96417 | 0% | 516 | $0.00 | |
| 3078F | 0% | 4,871 | $0.00 | |
| 93308 | 0% | 34 | $0.00 | |
| 01961 | 0% | 95 | $0.00 | |
| J9190 | Injection, fluorouracil, 500 mg | 0% | 27 | $0.00 |
| 01960 | 0% | 286 | $0.00 | |
| 90691 | 0% | 399 | $0.00 | |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | 0% | 402 | $0.00 |
| 17003 | 0% | 160 | $0.00 | |
| 93224 | 0% | 108 | $0.00 | |
| 47562 | 0% | 77 | $0.00 | |
| 94729 | 0% | 224 | $0.00 | |
| J1453 | Injection, fosaprepitant, 1 mg | 0% | 37 | $0.00 |
| 90849 | 0% | 18 | $0.00 | |
| 90661 | 0% | 2,714 | $0.00 | |
| 96152 | 0% | 22 | $0.00 | |
| L3807 | Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 0% | 15 | $0.00 |
| J1380 | Injection, estradiol valerate, up to 10 mg | 0% | 43 | $0.00 |
| 87186 | 0% | 13 | $0.00 | |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 0% | 13 | $0.00 |
| 96153 | 0% | 134 | $0.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 127 | $0.00 |
| 25600 | 0% | 12 | $0.00 | |
| 11981 | 0% | 46 | $0.00 | |
| 80061 | Lipid panel | 0% | 103 | $0.00 |
| 93245 | 0% | 96 | $0.00 | |
| 73718 | 0% | 17 | $0.00 | |
| 84439 | 0% | 13 | $0.00 | |
| G9919 | Screening performed and positive and provision of recommendations | 0% | 37 | $0.00 |
| 92504 | 0% | 12 | $0.00 | |
| 11100 | 0% | 26 | $0.00 | |
| 20600 | 0% | 25 | $0.00 | |
| 96900 | 0% | 38 | $0.00 | |
| 0083A | 0% | 37 | $0.00 | |
| 82274 | 0% | 40 | $0.00 | |
| 99218 | 0% | 13 | $0.00 | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 0% | 16 | $0.00 |
| 95812 | 0% | 16 | $0.00 | |
| 92555 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.